
Synex Biotech Private Limited
Manufacturer and distributor of various concrete products, including bricks, pavers, and retaining wall panels.
Manufacturer and distributor of various concrete products, including bricks, pavers, and retaining wall panels.
Synex Biotech Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 September 2011 and has a history of 13 years and eight months. Its registered office is in Dhar, Madhya Pradesh, India.
The Corporate was formerly known as Pozzolana Concrete Products Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.53 Cr and a paid-up capital of Rs 4.52 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Saboo, Rudraksh Somani, and Sripriya Palod serve as directors at the Company.
Dhar, Madhya Pradesh, India
+91-XXXXXXXXXX
U26950MP2011PTC026692
026692
Private Limited Indian Non-Government Company
06 Sep 2011
30 Sep 2024
31 Mar 2024
Unlisted
Roc Gwalior
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Saboo ![]() | Director | 25-Jul-2017 | Current |
Rudraksh Somani ![]() | Director | 01-Jul-2017 | Current |
Sripriya Palod ![]() | Director | 19-Jun-2024 | Current |
Synex Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.42% decrease. The company also saw a substantial fall in profitability, with a 111.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 192.82%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Synex Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sunil Saboo is a mutual person
Sripriya Palod is a mutual person
₹15.00 Cr
₹8.00 Cr
Date | Lender | Amount | Status |
---|---|---|---|
10 Oct 2019 | Bank Of India | ₹15.00 Cr | Open |
18 Sep 2018 | Others | ₹8.00 Cr | Satisfied |
Unlock and access historical data on people associated with Synex Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synex Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synex Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Synex Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Sripriya Palod was appointed as a Director was appointed as a Director on 19 Jun 2024 & has been associated with this company since 10 months 21 days .
Synex Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
A charge with Bank Of India of Rs. 15.00 Cr registered on 10 Oct 2019 with Charge ID 100293509 was modified on 12 Oct 2021.
A charge with Bank Of India amounted to Rs. 15.00 Cr with Charge ID 100293509 was registered on 10 Oct 2019.
A charge registered on 18 Sep 2018 via Charge ID 100215431 with Others was fully satisfied on 26 Sep 2019.
Synex Biotech Private Limited was incorporated on 06 Sep 2011.
The authorized share capital of Synex Biotech Private Limited is ₹ 4.53 Cr and paid-up capital is ₹ 4.52 Cr.
Currently 3 directors are associated with Synex Biotech Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Synex Biotech Private Limited is Plot No. 66-A Sector -3 Industrial Area India, Pithampur, Madhya Pradesh, 454774.
The corporate identification number (CIN) of Synex Biotech Private Limited is U26950MP2011PTC026692 and the company number is 026692 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Synex Biotech Private Limited has fallen by -4.42%.
The financial reports for the fiscal year 2023 indicates that The net worth of Synex Biotech Private Limited has experienced an downturn of -192.82%.
As per the financial statements for fiscal Year 2023, The total open charges for Synex Biotech Private Limited amount to ₹ 15.00 Cr.
The most recent Balance Sheet for Synex Biotech Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
JM
AS